Replies to post #389394 on Amarin Corp Plc (AMRN)

[rosemountbomber]

Thanks Raf. Holding steady but look at that Lovaza go. You can’t tell me a lot of docs aren’t as dumb as rocks.

Because I don’t believe you can auto switch a V script to GL as it is not the same drug.

[Megc]

Thanks Raf!

[rafunrafun]

Scripts for week ending September 23, 2022

Drug Industry TRx: -1.2% w/w; +5.8% y/y

Vascepa
TRx 63,343; -1.7% (-1,121) w/w; -23.4% y/y
NRx 29,077; -2.4% (-719) w/w; -22.2% y/y
Ref 34,266; -1.2% (-401) w/w; -24.3% y/y

Lovaza (Fake & Brand)
TRx 63,845; -2.5% (-1,647) w/w; -0.5% y/y
NRx 31,051; -3.8% (-1,238) w/w; -0.4% y/y
Ref 32,794; -1.2% (-409) w/w; -0.7% y/y

Fake Vascepa
TRx 41,046; +2.5% (+1,003) w/w; As % of total V: 39.3%
NRx 20,297; +4.3% (+832) w/w; As % of total V: 41.1%
Ref 20,750; +0.8% (+171) w/w; As % of total V: 37.7%

Fake Vascepa by Manufacturer
Hikma - TRx 14,255; (-118) w/w; Generic share 34.8%; Total V share 13.7%
Reddy - TRx 19,488; (+1,364) w/w; Generic share 47.6%; Total V share 18.7%
Apotex - TRx 7,200; (-352) w/w; Generic share 17.6%; Total V share 6.9%

Vascepa + Fake Vascepa
TRx 104,389; -0.1% (-117) w/w; +2.5% y/y
NRx 49,374; +0.2% (+113) w/w; +2.5% y/y
Ref 55,016; -0.4% (-230) w/w; +2.5% y/y